Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients-Reference-Cited by-同舟云学术

Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients

Published:2021-12-30 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Bloemendal Martine¹²,Bol Kalijn F.¹²^ORCID,Boudewijns Steve¹²,Gorris Mark A.J.¹^ORCID,de Wilt Johannes H.W.³,Croockewit Sandra A.J.⁴,van Rossum Michelle M.⁵,de Goede Anna L.⁶,Petry Katja⁷,Koornstra Rutger H.T.⁸,Figdor Carl¹⁹,Gerritsen Winald R.²,Schreibelt Gerty¹,de Vries I. Jolanda M.¹

Affiliation:

1. Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the Netherlands

2. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands

3. Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands

4. Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands

5. Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands

6. Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands

7. Miltenyi Biotec GmbH, Bergisch Gladbach, Germany

8. Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands

9. Oncode Institute, Utrecht, the Netherlands

Funder

European Research Council Advanced Grant Artimmune

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.2015113

Reference65 articles.

1. Dendritic cells and the control of immunity

2. Cancer immunotherapy via dendritic cells

3. Clinical use of dendritic cells for cancer therapy

4. Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

5. IL-4 Down-Regulates Anaphylatoxin Receptors in Monocytes and Dendritic Cells and Impairs Anaphylatoxin-Induced Migration In Vivo

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals;Journal of Drug Targeting;2024-08-07

2. M2 Macrophage Classification of Colorectal Cancer Reveals Intrinsic Connections with Metabolism Reprogramming and Clinical Characteristics;Pharmacogenomics and Personalized Medicine;2024-07

3. Protein-assisted synthesis of chitosan-coated minicells enhance dendritic cell recruitment for therapeutic immunomodulation within pulmonary tumors;Carbohydrate Polymers;2024-06

4. Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy;Vaccines;2024-05-05

5. Dendritic Cells in Cancer Immunology and Immunotherapy;Cancers;2024-02-28